Clinical Trial Update: Cabozantinib in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial of cabozantinib in hepatocellular carcinoma (NCT04588051) and states that the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cabometyx (cabozantinib)

Snippet

Sponsor: Stephen Chan Lam | Conditions: HCC | Phase 2 | Status: ACTIVE_NOT_RECRUITING